Persistent bullous erythema multiforme treated with thalidomide

Authors

  • Lola Kuperman Wilder General Hospital of Acute Dr. José María Ramos Mejía, Autonomous City of Buenos Aires, Argentina
  • Simón Scarano General Hospital of Acute Dr. José María Ramos Mejía, Autonomous City of Buenos Aires, Argentina
  • Luciana Cabral Campana General Hospital of Acute Dr. José María Ramos Mejía, Autonomous City of Buenos Aires, Argentina
  • Marcelo Label General Hospital of Acute Dr. José María Ramos Mejía, Autonomous City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/da.v26i4.2158

Keywords:

persistent erythema multiforme, thalidomide, blister

Abstract

Erythema multiforme is an acute mucocutaneous syndrome whose diagnosis is based on the morphology of the lesions. The persistent clinical course is characterized by the continuous appearance of extended typical “target” lesions and/or atypical lesions with plaques and blisters. Treatment should be adjusted to the patient and the trigger. We report the case of a 59-year-old woman with persistent bullous erythema multiforme who was successfully treated with thalidomide.

Author Biographies

Lola Kuperman Wilder, General Hospital of Acute Dr. José María Ramos Mejía, Autonomous City of Buenos Aires, Argentina

Resident Medical Doctor. Dermatology Division, Ramos Mejía Hospital.

Simón Scarano, General Hospital of Acute Dr. José María Ramos Mejía, Autonomous City of Buenos Aires, Argentina

Medical Doctor, Former Chief of Residents. Dermatology Division, Ramos Mejía Hospital.

Luciana Cabral Campana, General Hospital of Acute Dr. José María Ramos Mejía, Autonomous City of Buenos Aires, Argentina

Staff Physician, Division of Dermatology, Ramos Mejía Hospital.

Ascribed Professor, University of Buenos Aires.

Marcelo Label, General Hospital of Acute Dr. José María Ramos Mejía, Autonomous City of Buenos Aires, Argentina

Doctor of Medicine, Staff Medical Doctor, Division of Dermatology, Ramos Mejía Hospital.

Ascribed Professor, University of Buenos Aires.

References

I. Sokumbi O, Wetter D. Clinical features, diagnosis, and treatment of erythema multiforme: a review for the practicing dermatologist. Int J Dermatol 2012:51;889-902.

II. Roujeau JC. Eritema multiforme. EMC-Dermatología 2017;51:1-9.

III. Lebrero JL, Villa CG, Tellez M, Kuyuc MA, et ál. Eritema multiforme por Parvovirus B19. Rev Argent Dermatol 2019;100:41-45.

IV. Giorgini C, Grasso V, Vassallo C. Eritema multiforme persistente: descrizione di un caso e revisione della letteratura. Boll Soc Med Chir Pavia 2013;126:113-116.

V. Ruiz T, Hidalgo Parra I, Reppel J, Caetano M, et ál. Eritema multiforme ampollar asociado a infección por virus herpes simple. Dermatol Argent 2015,21:138-141.

VI. -Pavlović MD, Karadaglić DM, Kandolf LO, Mijuskovic ZP. Persistent erythema multiforme: a report of three cases. J Eur Arcad Dermatol Venerol 2001;15:54-58.

VII. Elgueta-Noy A, Aluzoro A, Martínez MJ, León M, et ál. Eritema multiforme ampollar extenso asociado a infección por virus herpes simple. Rev Argent Dermatol 2009;90:210-216.

VIII. Chen CW, Tsai TF, Chen YF, Hung CM. Persistent erythema multiforme treated with thalidomide. Am J Clin Dermatol 2008;9:123-127.

IX. Wetter DA, Davis MD. Recurrent erythema multiforme: clinical characteristics, etiologic associations, and treatment in a series of 48 patients at Mayo Clinic, 2000 to 2007. J Am Acad Dermatol 2010;62:45-53.

X. De Risi-Pugliese T, Sbidian E, Ingen-Housz-Oro S, Le Cleach L. Interventions for erythema multiforme: a systematic review. J Eur Acad Dermatol Venereol 2019;33:842-849.

Downloads

Published

2020-12-20

Issue

Vol. 26 No. 4 (2020): October-December 2020

Section

Clinical Cases

License

El/los autor/es tranfieren todos los derechos de autor del manuscrito arriba mencionado a Dermatología Argentina en el caso de que el trabajo sea publicado. El/los autor/es declaran que el artículo es original, que no infringe ningún derecho de propiedad intelectual u otros derechos de terceros, que no se encuentra bajo consideración de otra revista y que no ha sido previamente publicado.

 

Le solicitamos haga click aquí para imprimir, firmar y enviar por correo postal la transferencia de los derechos de autor